Ista Vitrase Could Get Restricted Vitreous Hemorrhage Indication, Firm Says
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
Approval of Ista’s Vitrase in vitreous hemorrhage would likely be restricted to patients with diabetic retinopathy as an underlying cause, Ista suggested.